tiprankstipranks
Trending News
More News >
Aptevo Therapeutics Inc (APVO)
NASDAQ:APVO
US Market

Aptevo Therapeutics (APVO) Financial Statements

Compare
741 Followers

Aptevo Therapeutics Financial Overview

Aptevo Therapeutics's market cap is currently $9.04M. The company's EPS TTM is $-40.14; its P/E ratio is >-0.01; Aptevo Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-8.10. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 3.11M$ 12.29M$ 4.31M
Gross Profit$ -352.00K$ 0.00$ 3.11M$ 12.29M$ -13.54M
Operating Income$ -24.60M$ -28.88M$ -28.64M$ -21.40M$ -27.49M
EBITDA$ -23.78M$ -28.31M$ -27.74M$ -20.26M$ -26.19M
Net Income$ -24.13M$ -17.41M$ 8.03M$ -28.46M$ -17.75M
Balance Sheet
Cash & Short-Term Investments$ 8.71M$ 16.90M$ 22.64M$ 45.04M$ 39.98M
Total Assets$ 15.59M$ 24.84M$ 34.22M$ 56.60M$ 53.55M
Total Debt$ 4.63M$ 5.40M$ 9.54M$ 16.71M$ 27.41M
Net Debt$ -4.08M$ -11.51M$ -13.10M$ -28.33M$ -12.56M
Total Liabilities$ 10.84M$ 12.62M$ 16.24M$ 55.38M$ 36.95M
Stockholders' Equity$ 4.75M$ 12.22M$ 17.97M$ 1.22M$ 16.59M
Cash Flow
Free Cash Flow$ -23.79M$ -11.73M$ -21.05M$ -22.39M$ -29.41M
Operating Cash Flow$ -23.79M$ -11.73M$ -21.02M$ -21.68M$ -29.32M
Investing Cash Flow$ 0.00$ 0.00$ -29.00K$ -713.00K$ 28.03M
Financing Cash Flow$ 15.60M$ 6.00M$ -2.62M$ 26.16M$ 23.87M
Currency in USD

Aptevo Therapeutics Earnings and Revenue History

Aptevo Therapeutics Debt to Assets

Aptevo Therapeutics Cash Flow

Aptevo Therapeutics Forecast EPS vs Actual EPS